منابع مشابه
Lumiracoxib (Novartis).
Lumiracoxib, an inhibitor of cyclooxygenase 2 (COX-2), is under development by Novartis for the potential treatment of osteoarthritis, rheumatoid arthritis and pain. By late December 2000, phase III trials had been initiated and were ongoing in December 2001.
متن کاملFingolimod. Mitsubishi Pharma/Novartis.
Mitsubishi Pharma Corp and Novartis AG are developing fingolimod, an orally active immunosuppressant affecting lymphocyte re-circulation, for the potential prevention of transplant rejection and the treatment of autoimmune diseases, including multiple sclerosis. Fingolimodis a synthetic sphingosine analog that becomes phosphorylated in vivo and acts as a sphingosine-1-phosphate receptor agonist.
متن کاملThe UK Technical Information Centre
The UK Technical Information Centre (TIC, URL-3 1999) is one of a set of Internet-based services developed in the EC funded project CONNET (URL-1 1999). The TIC aims to provide a single source of information on any purchasable publication of relevance to the built environment in the UK. Over 220 publishers have been identified and it is estimated that information on about 50,000 publications wi...
متن کاملThe Novartis Foundation
before — a hotbed of gene therapy research. It was a remarkable opportunity. Mulligan was offered one laboratory at the Children's Hospital to work on the basic science of viral vectors, and a second laboratory in a central Harvard building that will manufacture the vectors for use in human trials. Despite all these enticements, Mulligan did not agree to move — and leave a position at the White...
متن کاملUK Centre for Bioscience, Higher Education Academy
In a recent publication in CBE—Life Sciences Education, Woodin et al. (2010) summarized the findings and recommendations of a range of meetings and reports that addressed the changing needs of biology undergraduate education in the United States. Here in the United Kingdom, members of the community supported by the UK Centre for Bioscience are very familiar with many of the issues raised in thi...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Nature
سال: 2000
ISSN: 0028-0836,1476-4687
DOI: 10.1038/35036712